North America Radiopharmaceuticals Market to 2032

Overview

The North America Radiopharmaceuticals Market is expected to reach a 6,997.57 USD Billion by 2032 and is projected to grow at a CAGR of 11.74% from 2025 to 2032.

Revenue, 2024 (USD Billion)

3,759.73

Forecast, 2032 (USD Billion)

6,997.57

CAGR, 2024 - 2032

11.74%

Report Coverage

North America

North America Radiopharmaceuticals Market 2018-2032 USD Billion

North America Radiopharmaceuticals Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 3,759.73 USD Billion
Projected Market Size (2032): 6,997.57 USD Billion
CAGR (2025-2032): 11.74%

Key Findings of North America Radiopharmaceuticals Market

The North America Radiopharmaceuticals Market was valued at 6,997.57 USD Billion in 2024.
The North America Radiopharmaceuticals Market is likely to grow at a CAGR of 11.74% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Nuclear Reactors in By Source Segment accounted for the largest share of the market with a revenue of 2,163.84 USD Billion
The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 12.65% during the forecast period from 2024 to 2032.

North America Radiopharmaceuticals Market Scope

North America Radiopharmaceuticals Market Segmentation & Scope

By Type

Therapeutic Radiopharmaceuticals
Diagnostic Radiopharmaceuticals

By Application

Therapeutic
Diagnostic

By Source

Cyclotrons
Nuclear Reactors

End User

Others
Ambulatory Surgical Centers
Cancer Research Institutes
Diagnostic Centers
Hospitals

North America Radiopharmaceuticals Market Data Coverage Insights

Study Period	2024-2032
Base Year	2021
Unit	Revenue in USD Billion
Market Value in 2024	3,759.73 USD Billion
Market Value in 2032	6,997.57 USD Billion
CAGR (2025-2032)	11.74%
Historic Data	2016-2023
Market Segments Covered	By Type,By Application,By Source,End User

Regional Insights:

Leading Market (2024-2032): North America, leading in terms of revenue 3,759.73 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,645.36 USD Billion in 2024.

Segments and Scope

North America Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in North America Radiopharmaceuticals Market to 2032 with a revenue of 2,036.87 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in North America Radiopharmaceuticals Market to 2032 with a Growth rate of 12.34 % in forecast period 2025-2032.
North America Radiopharmaceuticals Market to 2032, By By Application
- Diagnostic is the largest segment in North America Radiopharmaceuticals Market to 2032 with a revenue of 1,948.45 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in North America Radiopharmaceuticals Market to 2032 with a Growth rate of 12.37 % in forecast period 2025-2032.
North America Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in North America Radiopharmaceuticals Market to 2032 with a revenue of 2,163.84 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in North America Radiopharmaceuticals Market to 2032 with a Growth rate of 12.24 % in forecast period 2025-2032.
North America Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in North America Radiopharmaceuticals Market to 2032 with a revenue of 1,317.41 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Radiopharmaceuticals Market to 2032 with a Growth rate of 12.65 % in forecast period 2025-2032.

North America Radiopharmaceuticals Market Company Share Analysis

Company Name
Cardinal Health
Advanced Accelerator Applications, A Novartis Company
GE HealthCare
Lantheus
Curium and its affiliates

North America Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Radiopharmaceuticals Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the North America Radiopharmaceuticals Market?

The North America Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.

What is the current market size of the North America Radiopharmaceuticals Market?

North America Radiopharmaceuticals Market was valued at USD 3,759.73(Revenue in USD Billion) in 2021.

What is the expected growth rate of the North America Radiopharmaceuticals Market?

North America Radiopharmaceuticals Market is projected to grow at a CAGR of 11.74% during the forecast period of 2024 to 2032.

Which is the dominating segment in the North America Radiopharmaceuticals Market?

The Nuclear Reactors segment is expected to dominate the North America Radiopharmaceuticals Market, holding a largest market share of 2,163.84 USD Billion in 2024